CLINICAL_TRIALS
trial_result
· 2019-12-04
Clinical Trial Update: PF-06741086 Multiple Dose Study in Severe Hemophilia [Phase 2]
Summary
Phase 2 multiple-dose study of PF-06741086 in severe hemophilia completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hemophilia A or B | Phase 2 | Status: COMPLETED | Results posted: 2019-12-04